Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Rosetta Genomics Ltd
OTC:ROSGQ

Watchlist Manager
Rosetta Genomics Ltd Logo
Rosetta Genomics Ltd
OTC:ROSGQ
Watchlist
Price: 0.0002 USD Market Closed
Market Cap: $1.2k
Write Note Create Alert Ask AI

Operating Margin

-219.6%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-219.6%
=
Operating Income
$-12.8m
/
Revenue
$5.8m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-219.6%
=
Operating Income
$-12.8m
/
Revenue
$5.8m

Peer Comparison

Country Company Market Cap Operating
Margin
IL
Rosetta Genomics Ltd
OTC:ROSGQ
1.2k USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
383.2B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.2B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
181.9B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.9B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.7B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 89% of companies in Israel
Percentile
11th
Based on 734 companies
11th percentile
-219.6%
Low
-84 760% — -5.8%
Typical Range
-5.8% — 10.9%
High
10.9% — 23 869.1%
Distribution Statistics
Israel
Min -84 760%
30th Percentile -5.8%
Median 4%
70th Percentile 10.9%
Max 23 869.1%

Other Profitability Ratios

Rosetta Genomics Ltd
Glance View

Market Cap
1.2k USD
Industry
Biotechnology

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The firm is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY and RosettaGX Reveal. The firm's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The firm focuses on developing diagnostic assay, RosettaGX Reveal V2. The company is also focusing on developing Bladder cancer risk stratification.

ROSGQ Intrinsic Value
Not Available
What is Intrinsic Value?

See Also

Summary
ROSGQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
ROSGQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ROSGQ stock valuation using valuation multiples.
Wall Street Estimates
ROSGQ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ROSGQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-219.6%
=
Operating Income
$-12.8m
/
Revenue
$5.8m
How has Operating Margin changed over time?

Over the last 3 years, Rosetta Genomics Ltd’s Operating Margin has increased from -1 270.4% to -219.6%. During this period, it reached a low of -1 270.4% on Aug 30, 2014 and a high of -151.5% on Mar 31, 2016.

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.